Overview: Galactosemia Newborn Screen TestIntroduction: The Galactosemia Newborn Screen Test screens newborns for galactosemia to prevent liver damage or developmental delays. Aligned with 2023 AAP guidelines, it uses an immunoassay for high sensitivity, aiding in newborn screening. This test is critical for early detection and improving outcomes in clinical pathology for newborns.
Other Names: Newborn Galactosemia Assay, Neonatal Metabolic Screen.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Galactosemia newborn screening began in the 1960s with metabolic research. Immunoassays improved in the 1990s, enhancing screening accuracy.
Purpose: Screens newborns for galactosemia, prevents complications, and monitors galactose metabolism markers.
Test Parameters: 1. Galactose Metabolism Markers
Pretest Condition: No fasting required. Collect dried blood spots within 24-48 hours of birth. Report family history of galactosemia.
Specimen: 3-5 dried blood spots (DBS card). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document family history of galactosemia or neonatal jaundice. Include any known dietary exposures.
Consent: Written parental consent required, detailing the tests purpose, screening implications, and potential need for follow-up.
Procedural Considerations: Uses an immunoassay to detect galactose metabolism markers in dried blood spots. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper sample collection or storage can affect results. Early testing may yield false negatives.
Clinical Significance: Abnormal markers suggest galactosemia, prompting confirmatory testing. Normal results may require further screening.
Specialist Consultation: Consult a pediatrician or metabolic specialist for result interpretation.
Additional Supporting Tests: GALT mutation test, galactose test, or galactose-1-phosphate test to confirm galactosemia.
Test Limitations: False negatives may occur in newborns. Results require clinical correlation.
References: AAP Newborn Screening Guidelines, 2023; Pediatrics, Berry GT, 2022.
